Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826052) titled 'Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast Cancer' on Sept. 12.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Fudan University
Condition:
Breast Cancer
Adjuvant Therapy
Intervention:
Drug: CDK4/6 inhibitor
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 15, 2026
Target Sample Size: 494
To know more, visit https://clinicaltrials.gov/study/NCT07826052
Disclaimer: Curated by HT Syndication....